Skip to main content
BIAF
NASDAQ Industrial Applications And Services

bioAffinity Technologies Closes $4M Private Placement with Warrants

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.402
Mkt Cap
$3.258M
52W Low
$0.325
52W High
$13.5
52W Position info
24% above low
Off High info
97% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

BIAF sits 24% above its 52-week low of $0.325.

Summary

bioAffinity Technologies raised $4.0 million in a private placement of pre-funded warrants and two series of common stock purchase warrants, with net proceeds of about $3.6 million to fund working capital amid a going concern warning.


Key Events · Financing and Capital Events · BIAF

  • Private Placement Closed

    Closed a $4.0 million private placement on August 14, 2026, issuing 8,462,027 pre-funded warrants at $0.4657 each and Series A and Series B warrants to purchase up to 8,462,027 shares each at $0.4727.

  • Net Proceeds and Use

    Net proceeds are approximately $3.6 million after placement agent fees and expenses, to be used for working capital and general corporate purposes.

  • Potential Dilution

    If all warrants are exercised, up to 16,924,054 new shares could be issued, representing substantial dilution relative to the current market cap of $3.3 million.

  • Registration Rights

    Company agreed to file a resale registration statement within 15 days and use best efforts to have it effective within 45 days, creating a near-term overhang.


Analysis · BIAF · Industrial Applications And Services

bioAffinity Technologies closed a $4.0 million private placement on August 14, 2026, issuing pre-funded warrants and two series of common stock purchase warrants. The deal is priced at-the-market under Nasdaq rules, with a combined effective price of $0.4727 per share and accompanying warrants. Net proceeds of approximately $3.6 million provide critical working capital for a company that disclosed a going concern warning and a cash runway ending this month in its Q2 2026 filing. The warrants, exercisable at $0.4727 after stockholder approval, could add up to 16.9 million shares if fully exercised, representing significant potential dilution for existing holders. The company also granted the placement agent warrants for 253,861 shares and agreed to register the resale of all underlying shares within 45 days, creating a near-term overhang on the stock.

At the time of this filing, BIAF was trading at $0.40 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $0.33 to $13.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BIAF - Latest Insights

BIAF
Aug 14, 2026, 11:07 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.389
Real-time Price: $0.4021 info
Change: +$0.0131 (+3%) info
Market Cap: $3.258M info
BIAF
Aug 13, 2026, 9:07 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $0.469225
Real-time Price: $0.4021 info
Change: -$0.067125 (-14%) info
Market Cap: $3.258M info
BIAF
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.5085
Real-time Price: $0.4021 info
Change: -$0.1064 (-21%) info
Market Cap: $3.258M info
BIAF
Aug 07, 2026, 4:45 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.5098
Real-time Price: $0.4021 info
Change: -$0.1077 (-21%) info
Market Cap: $3.258M info
BIAF
Aug 07, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.5201
Real-time Price: $0.4021 info
Change: -$0.118 (-23%) info
Market Cap: $3.258M info